PleoPharma Wins $6.5 Million NIH Grant for Phase 3 Trial
PHOENIXVILLE, PA — PleoPharma Inc. secured a $6.5 million federal grant to advance a Phase 3 trial of its experimental treatment for cannabis withdrawal symptoms, providing three years of funding …
PleoPharma Wins $6.5 Million NIH Grant for Phase 3 Trial Read More